Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Apramycin Sulfate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 65710-07-8, Apramycin sulphate, Apramycin (sulfate), 8uyl6naz3q, Ai3-29795, 410097-64-2
    Molecular Formula
    C21H43N5O15S
    Molecular Weight
    637.7  g/mol
    InChI Key
    WGLYHYWDYPSNPF-RQFIXDHTSA-N
    FDA UNII
    8UYL6NAZ3Q
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2R,3R,4S,5S,6S)-2-[[(2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol;sulfuric acid
    2.1.2 InChI
    InChI=1S/C21H41N5O11.H2O4S/c1-26-11-14(30)18-8(33-20(11)37-21-16(32)13(29)10(25)9(4-27)34-21)3-7(24)19(36-18)35-17-6(23)2-5(22)12(28)15(17)31;1-5(2,3)4/h5-21,26-32H,2-4,22-25H2,1H3;(H2,1,2,3,4)/t5-,6+,7-,8+,9-,10-,11+,12+,13+,14-,15-,16-,17-,18+,19+,20-,21-;/m1./s1
    2.1.3 InChI Key
    WGLYHYWDYPSNPF-RQFIXDHTSA-N
    2.1.4 Canonical SMILES
    CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O.OS(=O)(=O)O
    2.1.5 Isomeric SMILES
    CN[C@H]1[C@H]([C@@H]2[C@H](C[C@H]([C@H](O2)O[C@@H]3[C@H](C[C@H]([C@@H]([C@H]3O)O)N)N)N)O[C@@H]1O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)N)O)O)O.OS(=O)(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    8UYL6NAZ3Q
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Apramycin

    2. Ebl-1003

    2.3.2 Depositor-Supplied Synonyms

    1. 65710-07-8

    2. Apramycin Sulphate

    3. Apramycin (sulfate)

    4. 8uyl6naz3q

    5. Ai3-29795

    6. 410097-64-2

    7. Apramycin Sulfate Salt

    8. (2r,3r,4s,5s,6s)-2-[[(2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-[(1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol Sulfuric Acid

    9. (2r,3r,4s,5s,6s)-2-[[(2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-[(1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol;sulfuric Acid

    10. (2r,3r,4s,5s,6s)-5-amino-2-(((2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-(((1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4-diol Sulfate

    11. Ino-6-(hydroxymethyl)oxane-3,4-diol;sulfuric Acid

    12. Unii-8uyl6naz3q

    13. (2r,3r,4s,5s,6s)-2-[[(2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-[(1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-am

    14. Einecs 265-890-7

    15. Apramycin, Sulfate (2:5)

    16. Schembl94999

    17. (+)-apramycin Sulfate

    18. Apramycin Sulfate [mart.]

    19. Chebi:190734

    20. Hy-b1329

    21. Mfcd06200257

    22. S4254

    23. Akos016010323

    24. Apramycin Sulfate [green Book]

    25. Ccg-270308

    26. Cs-4854

    27. Apramycin Sulfate Salt, >=95% (tlc)

    28. As-35223

    29. 710a078

    30. A923667

    31. W-104790

    32. Apramycin Sulfate, Antibiotic For Culture Media Use Only

    33. (2r,3r,4s,5s,6s)-2-[[(2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-[(1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol;suluric Acid

    34. (2r,3r,4s,5s,6s)-5-amino-2-(((2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-(((1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4-diol Xsulfate

    35. (2r,3r,4s,5s,6s)-5-amino-2-(((2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-(((1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4-diolxsulfate

    36. D-streptamine, O-4-amino-4-deoxy-.alpha.-d-glucopyranosyl-(1-8)-o-(8r)-2-amino-2,3,7-trideoxy-7-(methylamino)-d-glycero-.alpha.-d-allo-octodialdo-1,5:8,4-dipyranosyl-(1-4)-2-deoxy-, Sulfate

    37. D-streptamine, O-4-amino-4-deoxy-alpha-d-glucopyranosyl-(1-8)-o-(8r)-2-amino-2,3,7-trideoxy-7-(methylamino)-d-glycero-alpha-d-allo-octadialdo-1,5:8,4-dipyranosyl-(1-4)-2-deoxy-, Sulfate (salt)

    2.4 Create Date
    2005-08-09
    3 Chemical and Physical Properties
    Molecular Weight 637.7 g/mol
    Molecular Formula C21H43N5O15S
    Hydrogen Bond Donor Count13
    Hydrogen Bond Acceptor Count20
    Rotatable Bond Count6
    Exact Mass637.24763686 g/mol
    Monoisotopic Mass637.24763686 g/mol
    Topological Polar Surface Area367 Ų
    Heavy Atom Count42
    Formal Charge0
    Complexity841
    Isotope Atom Count0
    Defined Atom Stereocenter Count17
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anti-Bacterial Agents

    Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)